Mineralys Therapeutics, Inc. Profile Avatar - Palmy Investing

Mineralys Therapeutics, Inc.

Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and associated cardiovascular diseases. It clinical-stage product candidate is lorundrostat, a proprietary, orally administ…

Biotechnology
US, Radnor [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
% YoY
% 3Yr
% 5Yr
% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Download
Cash Amount Pay Date
Download
Cash Amount Pay Date
End of MLYS's Analysis
CIK: 1933414 CUSIP: 603170101 ISIN: US6031701013 LEI: - UEI: -
Secondary Listings
MLYS has no secondary listings inside our databases.